APOE and type 2 diabetes mellitus: Baseline prevalence of T2DM was marginally lower in APOE4+ (0.81 [0.64–1.01], p = .06) but did not differ between APOE2+ (1.24 [0.97–1.59], p = .09) and APOE3 carriers (Supplementary Table 4).